NEW YORK (GenomeWeb) – Waters reported today that its first quarter revenues rose 7 percent year over year, as the company saw solid demand among its pharma customers but a decline in sales of its mass spectrometry instruments.

Waters posted revenues of $530.7 million for the quarter compared to $498 million in Q1 2017, below the average Wall Street estimate of $535.3 million.

Currency translation increased sales growth by around 5 percent, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.